raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:313772

Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome

Synonyms: AFG3L2-related spastic ataxia-myoclonic epilepsy-neuropathy syndrome · Autosomal recessive spastic ataxia type 5 · SPAX5

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood
Status
active

Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome is a rare hereditary spastic ataxia disorder characterized by childhood onset of slowly progressive lower limb spastic paraparesis and cerebellar ataxia (with dysarthria, swallowing difficulties, motor degeneration), associated with sensorimotor neuropathy (including muscle weakness and distal amyotrophy in lower extremities) and progressive myoclonic epilepsy. Ocular signs (ptosis, oculomotor apraxia), dysmetria, dysdiadochokinesia, dystonic movements and myoclonus may also be associated.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enEarly-onset spastic ataxia-myoclonic epilepsy-neuropathy syndromeAFG3L2-related spastic ataxia-myoclonic epilepsy-neuropathy syndrome · Autosomal recessive spastic ataxia type 5 · SPAX5
frSyndrome d'ataxie spastique-epilepsie myoclonique-neuropathie précoceAtaxie spastique autosomique récessive type 5 · SPAX5 · Syndrome d'ataxie spastique-epilepsie myoclonique-neuropathie associé à AFG3L2
deFrüh beginnende spastische Ataxie-myoklonische Epilepsie-Neuropathie-SyndromAtaxie, spastische, autosomal-rezessive, Typ 5 · SPAX5 · Spastische Ataxie, autosomal-rezessive, Typ 5 · Spastische Ataxie-Neuropathie-Syndrom, AFG3L2-assoziiertes
esSíndrome de ataxia espástica-epilepsia mioclónica-neuropatía de inicio precozSíndrome de ataxia espástica-neuropatía asociado al gen AFG3L2 · Ataxia espástica autosómica recesiva tipo 5 · SPAX5 · Síndrome asociado al gen AFG3L2 de ataxia espástica-epilepsia mioclónica-neuropatía
itSindrome da atassia spastica, epilessia mioclonica e neuropatia ad esordio precoceAtassia spastica autosomica recessiva 5 · SPAX5 · Sindrome atassia spastica-neuropatia, AFG3L2-correlata
nlVroeg optredende spastisch ataxie - myoclonische epilepsie - neuropathie-syndroomAFG3L2-geassocieerde spastische ataxie - myoclonische epilepsie - neuropathie-syndroom · Autosomaal recessieve spastische ataxie type 5 · SPAX5
ptSíndrome de ataxia espástica-epilepsia mioclónica-neuropatia de início precoceAtaxia espástica autossómica recessiva tipo 5 · SPAX5 · Síndrome de ataxia-neuropatia espástica associada ao AFG3L2
plZespół ataksja spastyczna o wczesnym początku – padaczka miokloniczna - neuropatiaAutosomalna recesywna ataksja spastyczna typu 5 · SPAX5 · Zespół ataksja spastyczna związana z AFG3L2-neuropatia
csSpastická ataxie a neuropatie s časným nástupemSyndrom zahrnující AFG3L2-vázanou spastickou ataxii a neuropatii · SPAX5 · Autozomálně recesivní spastická ataxie, typ 5
ukСиндром ранньої спастичної атаксії-міоклонічної епілепсії-нейропатіїСиндром спастичної атаксії-міоклонічної епілепсії-нейропатії, повязаний з AFG3L2 · Аутосомно-рецесивна спастична атаксія типу 5 · SPAX5
zh早发性痉挛性共济失调-肌阵挛性癫痫-神经病变综合征AFG3L2基因相关痉挛性共济失调-肌阵挛性癫痫-神经病变综合征
trErken başlangıçlı spastik ataksi-miyoklonik epilepsi-nöropati sendromuSPAX5 · Otozomal çekinik spastik ataksi tip 5 · AFG3L2-ilişkili spastik ataksi-miyoklonik epilepsi-nöropati sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM614487Evalidated
ICD-10G11.4NTBTattributedvalidated
ICD-118A03.1YNTBTattributedvalidated
MONDO0013776Evalidated
UMLSC3280977Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
AFG3L2Disease-causing germline mutation(s) inAssessedHGNC:315ENSG0000014138560458118p11.21AFG3 like matrix AAA peptidase subunit 222022284[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_22022284[PMID]
Cases/families2 casesWorldwideCase(s)Validated22022284[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

24 annotations · validated 2018-05-02
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0008316Abnormal mitochondria in muscle tissue
HP:0001251Ataxia
HP:0002069Bilateral tonic-clonic seizure
HP:0001272Cerebellar atrophy
HP:0001321Cerebellar hypoplasia
HP:0007108Demyelinating peripheral neuropathy
HP:0003693Distal amyotrophy
HP:0002460Distal muscle weakness
HP:0002075Dysdiadochokinesis
HP:0001310Dysmetria
HP:0002015Dysphagia
HP:0001332Dystonia
HP:0002353EEG abnormality
HP:0002123Generalized myoclonic seizure
HP:0001256Intellectual disability, mild
HP:0007340Lower limb muscle weakness
HP:0001336Myoclonus
HP:0000657Oculomotor apraxia
HP:0003477Peripheral axonal neuropathy
HP:0000508Ptosis
HP:0007141Sensorimotor neuropathy
HP:0002464Spastic dysarthria
HP:0002313Spastic paraparesis
HP:0001257Spasticity

Annotation source: 22022284[PMID]_25401298[PMID]

7

Sources for this card